Universal Security Instruments, Inc. - 10-Q Summary
Business Context and Reporting Period
This is a Quarterly Report (Form 10-Q) for Universal Security Instruments, Inc. for the period ended June 30, 2006. The Company manufactures and distributes security products, including smoke alarms, carbon monoxide alarms, and ground fault circuit interrupters (GFCI). It maintains a 50% interest in a Hong Kong Joint Venture responsible for manufacturing.
Key Financial Metrics
| Metric | Q2 2006 | Q2 2005 |
|---|---|---|
| Net Sales | $8,038,437 | $6,923,810 |
| Gross Profit | $2,780,517 | $2,048,954 |
| Gross Margin | 34.6% | 29.6% |
| Operating Income | $881,392 | $108,716 |
| Net Income | $1,577,468 | $889,770 |
| Diluted EPS | $0.83 | $0.50 |
| Cash and Equivalents | $2,520,233 | $117,496 |
| Factoring Line Availability | $7,396,000 | N/A |
Joint Venture Performance: The Hong Kong Joint Venture reported net sales of $9,043,990 and net income of $2,244,414 for the quarter. The Company recorded $1,052,979 in equity earnings from this venture.
Material Changes vs. Prior Period
- Revenue Growth: Net sales increased 16.1% year-over-year, driven by higher sales across core product lines.
- Margin Expansion: Gross profit margin improved by 5.0 percentage points to 34.6%, attributed to costs not rising at the same rate as sales.
- Expense Reduction: Selling, general, and administrative (SG&A) expenses decreased by $41,247. Professional fees dropped significantly ($438,356) due to lower legal fees, partially offset by increased salaries, commissions, and $75,000 in Sarbanes-Oxley compliance costs.
- Cash Flow: Operating activities used $884,667 in cash, a reversal from the $60,170 provided in the prior year. This was primarily due to increases in inventory, accounts receivable, and prepaid expenses, alongside the non-cash equity earnings from the Joint Venture.
- Accounting Change: The Company adopted SFAS No. 123R effective April 1, 2006, resulting in an $8,413 reduction in net income due to stock-based compensation expense.
Outlook, Risks, and Contingencies
- Liquidity: Management believes current resources, including a $7.5 million Factoring Agreement (with $7.396 million available) and an unsecured $250,000 line of credit, are sufficient for the next 12 months.
- Legal Proceedings: The Company maintains a reserve of $669,844 for patent litigation and settlement. The Joint Venture is pursuing legal action against a German company for patent infringement, which increased professional fees.
- Compliance Costs: The Company anticipates $300,000 in Sarbanes-Oxley compliance costs for the fiscal year ending March 31, 2007.
- Internal Controls: Management noted a lack of segregation of duties due to a small staff but deemed the risk insignificant given current controls.
Investor Verification Checklist
- Verify the sustainability of the 5.0% gross margin expansion and whether cost structures can remain favorable as sales volumes fluctuate.
- Monitor the status of the patent litigation reserve ($669,844) and the outcome of the Joint Venture's legal action in Germany.
- Assess the impact of the $1.5 million increase in working capital (inventory and receivables) on future cash flow requirements.
- Confirm the continued availability of the $7.5 million Factoring Agreement, which is critical for financing foreign inventory purchases.
- Review the adoption of SFAS No. 123R and its ongoing impact on reported net income and EPS.